SCHEMBL30544050

SCHEMBL30544050

COc1ccc(F)cc1NC(=O)c1csc(C(=O)Nc2cccc(NS(C)(=O)=O)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.53
▸ KDM4E B2RXH2 4/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ LMNA P02545 5/20 0.46
▸ KMT2A Q03164 6/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ GAA P10253 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25366920 1.00 ALDH1A1 (0.53) ALDH1A1KDM4EL3MBTL1LMNAKMT2A
SCHEMBL25368034 0.81 KMT2A (0.60) ALDH1A1L3MBTL1LMNAKMT2AMEN1
SCHEMBL25369870 0.81 MRGPRX1 (0.46) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL25368280 0.81 DHX9 (0.53) ALDH1A1KDM4EL3MBTL1LMNAKMT2A
SCHEMBL30543946 0.81 DHX9 (0.53) ALDH1A1KDM4EL3MBTL1LMNAKMT2A
SCHEMBL30543909 0.80 ATM (0.49) ALDH1A1L3MBTL1LMNAKMT2AMEN1
SCHEMBL25367764 0.80 ATM (0.49) ALDH1A1L3MBTL1LMNAKMT2AMEN1
SCHEMBL30543904 0.79 DHX9 (0.50) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL25368623 0.79 DHX9 (0.50) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL25368096 0.79 RAB9A (0.53) ALDH1A1L3MBTL1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479380-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 — — EP disclosed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 — — WO disclosed
Send feedback